Press Releases

The Assistance Fund Opens New Program for Primary Hyperoxaluria

FOR IMMEDIATE RELEASE

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Primary Hyperoxaluria

ORLANDO, Fla., January 11, 2021—The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with primary hyperoxaluria. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copayments, health insurance premiums, and incidental medical expenses related to the condition.

Primary hyperoxaluria is a rare, genetic condition that causes the overproduction of oxalate, which can result in frequent kidney stones and crystals. This process can permanently damage the kidneys and eventually cause them to stop working.¹

“Thanks to our generous donors, The Assistance Fund is pleased to announce the launch of our new Primary Hyperoxaluria Financial Assistance Program,” said Mark P. McGreevy, President and CEO of The Assistance Fund. “People living with primary hyperoxaluria must manage incredible physical and mental stress related to their condition; we are thrilled to remove from the equation the financial pressure of accessing treatment.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (855) 718-1196 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages more than 70 disease programs, each of which covers the FDA-approved medications that treat a specific disease. Since our founding in 2009, The Assistance Fund has helped nearly 135,000 children and adults access critical treatment for a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact
Margaret Figley
Director of Communications
margaret.figley@tafcares.org

¹ “Primary hyperoxaluria type 1.” Genetic and Rare Diseases Information Center, NIH. (October 26, 2020). Retrieved from: https://rarediseases.info.nih.gov/diseases/2835/primary-hyperoxaluria-type-1.

Share This
Categories: Press Releases
Close Menu-Close

Need help finding something?

Explore our site